A study on siddha trail drug Muruvili Kudineer(int) in patients having Singimantha kanam

Phase 2

Recruiting

• Conditions: Singimantha kanam(Bronchitis)

• Registration Number: CTRI/2018/04/013286
• Lead Sponsor: Government Siddha Medical College

Brief Summary

This is a Single Non randomized open clinical trial to study the safety and efficacy of Siddha trial drug Muruvili Kudineer. The trial drug is given 15 - 30 ml twice a day for 2 consecutive cycles.Clinical trial is conducted after conducting pre clinical toxicity study. During the trial all the study related data will be recorded and documented.After the completion of trial all the data will be analysed statistically.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-10-07
• Last Update Posted: 2018-04-04

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Age 3-13years Sex:Both Male and Female children Fever Dynpnea Dry or Productive cough Wheezing Patients who are all willing to give blood samples at subsequent visit are involved in this study.

Exclusion Criteria

Allergic rhinitis Asthma Refluxoesophagitis Upper respiratory infections/common cold Bronchiolitis.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome is mainly assessed by BS Score reduction in clinical symptoms like fever, cough, sputum, dyspnea, wheezing before and after treatment	7 days

Secondary Outcome Measures

Name	Time	Method
Secondary outcome is assessed by comparing the safety parameters before and after treatment	7 days

Trial Locations

Locations (1)

Aringar Anna Government hospital of Indian Medicine; 🇮🇳 Chennai, TAMIL NADU, India

Aringar Anna Government hospital of Indian Medicine

🇮🇳Chennai, TAMIL NADU, India

Dr Abisha A

Principal investigator

8056202613

abishabsms@gmail.com